Tuesday, March 17, 2026

Team USA Skater Corinne Stoddard Apologizes After Kim Gil Li Crash In 1.24-Mile Mixed Relay

U.S. skater Corinne Stoddard apologized for colliding with South Korea's Kim Gil Li at the Winter Olympics, impacting their race outcome.

North Korean Leader Orders Redesign of Transport Hub, Emphasizes Functionality and Planning

Kim Jong Un inspected major construction projects in North Korea, emphasizing multifunctionality and progress in greenhouse and embankment development.

Underweight People Face Higher Suicide Risk, Study Shows

A study reveals underweight individuals face a higher suicide risk, while overweight individuals show a lower risk, emphasizing BMI's impact.

Tag: precision medicine

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

How Keytruda is Revolutionizing Cancer Treatment: Expanded Coverage for Stomach Cancer in 2026

Keytruda's insurance coverage expands to stomach cancer, solidifying its status as a leading universal immunotherapy for various cancers.

3Billion Joins Global iHope Program for Rare Disease Diagnosis: A Game-Changer for Patients in Asia

3Billion becomes the first Asian partner in the iHope program, enhancing rare disease diagnostics for underserved pediatric patients globally.

K-Biohealth Surge: How AI and Precision Medicine are Transforming Global Markets in 2026

South Korean biohealth firms are expanding globally, showcasing AI solutions and forming partnerships at major healthcare events.

How Tumor Microenvironment Stiffness Fuels Cancer Aggressiveness: Key Insights from Pusan National University

A study reveals that tumor microenvironment stiffness increases cancer aggressiveness and treatment resistance, highlighting its significance in treatment strategies.

Breakthrough Tech Tailors Gene Editing to Your DNA

Researchers at Pusan National University developed a tool for personalized gene editing, predicting side effects based on DNA variations.

New Drug Candidate Shows Promise Against Solid Tumors by Eliminating M2 Macrophages

Researchers have developed a peptide drug that targets M2 macrophages, enhancing solid tumor immunotherapy effectiveness.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.